Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037968 | SCV000061634 | benign | not specified | 2012-01-31 | criteria provided, single submitter | clinical testing | Arg25Cys in exon 1 of NKX2-5: This variant has been reported in a large number o f individuals with congenital heart disease (Akcaboy 2008, Benson 1999, DeLuca 2 010, Esposito 2009, Goli-Pereira 2010, Goldmuntz 2001, McElhinny 2003, Raunch 20 10, Stallmeyer 2010). This variant is now considered to be benign based on its h igh population frequency (2.6%) in the Black population (97/3694 chromosomes, NH LBI Exome Variant Project http://evs.gs.washington.edu/EVS/). |
Genetic Services Laboratory, |
RCV000037968 | SCV000194075 | uncertain significance | not specified | 2015-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037968 | SCV000223572 | benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000987632 | SCV000262103 | benign | Atrial septal defect 7 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000037968 | SCV000310346 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000619696 | SCV000735169 | benign | Cardiovascular phenotype | 2015-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000987632 | SCV001137025 | likely benign | Atrial septal defect 7 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003311655 | SCV004011640 | benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | NKX2-5: BS1, BS2 |
OMIM | RCV000009572 | SCV000029790 | pathogenic | Tetralogy of Fallot | 2011-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV000009573 | SCV000029791 | pathogenic | Hypothyroidism, congenital, nongoitrous, 5 | 2011-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV000023017 | SCV000044308 | pathogenic | Aortic arch interruption | 2011-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV000023018 | SCV000044309 | pathogenic | Truncus arteriosus | 2011-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV000023019 | SCV000044310 | pathogenic | Hypoplastic left heart syndrome 2 | 2011-08-01 | no assertion criteria provided | literature only | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030339 | SCV000053006 | benign | Congenital heart disease | 2015-06-04 | no assertion criteria provided | clinical testing |